great
progress
achiev
millennium
develop
goal
reduc
child
mortal
rate
twothird
number
death
children
decreas
almost
million
million
although
infecti
diseas
still
major
diseas
diarrhea
malaria
account
death
children
younger
year
old
estim
lower
respiratori
tract
infect
caus
million
death
children
younger
year
old
death
decreas
observ
episod
childhood
pneumonia
young
children
million
million
number
death
pneumonia
million
million
malnutrit
predispos
factor
recurr
sever
infect
includ
zinc
defici
approxim
billion
peopl
develop
countri
suffer
zinc
defici
mainli
due
malnutrit
estim
preval
inadequ
zinc
intak
vari
highincom
region
south
asia
case
mexico
estim
preval
inadequ
zinc
intak
zinc
micronutri
play
import
role
cell
prolifer
differenti
immun
function
act
cofactor
protein
structur
catalyt
function
enzym
transcript
factor
zinc
promot
neutrophil
extracellular
trap
induc
cellmedi
immun
humor
immun
regul
factor
differenti
modul
proinflammatori
respons
target
control
oxid
stress
regul
inflammatori
cytokin
zinc
defici
promot
thymic
atrophi
lymphopenia
decreas
innat
adapt
immun
impair
host
defens
neutrophil
natur
killer
cell
phagocytosi
intracellular
kill
activ
cytokin
product
macrophag
alter
prolifer
cytokin
product
antibodi
secret
b
cell
world
health
organ
unicef
recommend
sinc
zinc
supplement
along
oral
rehydr
treat
acut
diarrhea
benefit
zinc
shorten
decreas
sever
report
numer
random
placebocontrol
trial
case
zinc
supplement
children
pneumonia
result
controversi
studi
report
margin
improv
hospit
stay
other
report
differ
tachypnea
respiratori
distress
day
resolut
pneumonia
compar
control
other
report
improv
clinic
outcom
durat
hospit
stay
prevent
mortal
incid
preval
includ
children
hiv
decreas
day
hospit
stay
observ
report
higher
basal
zinc
better
nutrit
statu
effect
zinc
time
clinic
resolut
studi
uganda
report
decreas
mortal
children
month
year
old
pneumonia
decreas
rel
risk
mortal
cellmedi
immun
play
import
role
host
defens
virus
bacteria
zinc
supplement
children
degre
malnutrit
sever
infect
could
improv
immun
respons
acut
infect
report
assess
immun
respons
children
pneumonia
receiv
zinc
supplement
along
standard
pneumonia
treatment
detect
etiolog
agent
multiplex
pcr
aim
studi
evalu
immunomodulatori
effect
zinc
supplement
correl
clinic
respons
etiolog
agent
children
pneumonia
younger
year
old
previous
healthi
children
month
year
old
clinic
andor
radiolog
diagnosi
pneumonia
admit
hospit
gener
de
mexico
dr
eduardo
liceaga
hospit
de
includ
verylowincom
popul
mexico
citi
metropolitan
area
attend
hospit
case
definit
pneumonia
child
sign
symptom
includ
fever
cough
tachycardia
tachypnea
dyspnea
respiratori
distress
rale
andor
radiograph
pattern
pneumonia
inclus
criteria
previous
healthi
children
case
definit
pneumonia
exclus
criteria
zinc
intak
previou
week
histori
cardiac
andor
pulmonari
diseas
includ
asthma
prematur
studi
approv
institut
review
board
faculti
medicin
universidad
nacion
de
hospit
gener
de
hospit
de
written
consent
obtain
parent
guardian
procedur
follow
accord
ethic
standard
helsinki
declar
tripleblind
random
control
clinic
trial
conduct
princip
investig
gener
random
alloc
sequenc
pediatrician
recruit
patient
patient
mother
laboratori
technician
perform
immunolog
molecular
test
know
receiv
zinc
placebo
time
admiss
hospit
parent
guardian
invit
children
pneumonia
particip
studi
sign
inform
consent
children
randomli
assign
use
list
random
number
gener
epistat
receiv
zinc
sulfat
mg
children
younger
year
old
mg
children
older
year
old
placebo
mg
glucos
list
gener
princip
investig
particip
assign
group
pediatrician
recruit
patient
zinc
placebo
contain
ident
paper
contain
mark
b
dilut
ml
distil
water
administ
everi
day
oral
throughout
durat
hospit
substanc
look
like
white
powder
insid
envelop
dilut
distil
water
also
look
inclus
child
demograph
clinic
characterist
laboratori
workup
chest
xray
risk
factor
pneumonia
obtain
followup
clinic
record
includ
heart
rate
oxygen
satur
respiratori
distress
temperatur
cough
rale
wheez
feed
capac
record
period
six
time
day
discharg
patient
special
format
design
studi
nurs
record
vital
sign
two
time
per
shift
hospit
sheet
three
shift
per
day
clinic
record
taken
record
verifi
pediatrician
patient
receiv
standard
treatment
protocol
children
pneumonia
includ
oxygen
supplement
intraven
fluid
accord
criteria
consult
physician
penicillin
ampicillin
administ
oseltamivir
influenza
suspect
two
blood
draw
obtain
one
child
admit
hospit
anoth
one
day
discharg
perform
lymphoprolifer
cytokin
assay
obtain
sera
frozen
process
determin
serum
zinc
level
nasal
wash
also
obtain
day
hospit
instil
ml
physiolog
salin
solut
steril
feed
tube
connect
syring
aspir
solut
nostril
place
content
viral
medium
store
process
detect
viral
bacteri
genet
materi
nasal
wash
blood
sampl
process
unidad
de
en
medicina
experiment
facultad
de
medicina
unam
zinc
sera
patient
hospit
discharg
determin
use
commerci
kit
zinc
monoliquid
fortressdiagnost
usa
fifti
microlit
serum
ad
reagent
npropylnsulfopropylamino
phenol
incub
min
compar
standard
moll
sampl
read
wavelength
nm
genesi
uvvi
spectrophotomet
thermo
scientif
signal
intens
directli
proport
amount
zinc
normal
serum
zinc
nasal
wash
process
use
anyplex
ii
kit
seegen
seoul
south
korea
nucleic
acid
extract
perform
manual
use
ribospin
geneal
vrd
kit
geneal
biotechnolog
seoul
south
korea
extract
intern
control
anyplex
kit
ad
sampl
cdna
synthes
extract
rna
cdna
synthesi
kit
premix
seegen
subsequ
realtim
pcr
carri
equip
biorad
anyplex
ii
detect
kit
use
toce
technolog
amplifi
respiratori
virus
visual
use
seegen
viewer
softwar
anyplex
kit
capac
detect
rna
virus
dna
virus
respiratori
syncyti
viru
type
b
influenza
viru
type
b
parainfluenza
viru
type
adenoviru
metapneumoviru
coronaviru
rhinoviru
type
b
c
enteroviru
bocaviru
bacteri
genet
materi
detect
nasal
wash
use
seeplex
ace
detect
kit
seegen
seoul
korea
simultan
detect
multiplex
pcr
use
dpo
technolog
kit
detect
streptococcu
pneumonia
haemophilu
influenza
chlamydophila
pneumonia
legionella
pneumophila
bordetella
pertussi
mycoplasma
pneumonia
fresh
peripher
blood
mononuclear
cell
pbmc
obtain
whole
blood
ficollhypaqu
densiti
gradient
pbmc
place
cell
per
well
rmpi
medium
gibco
gaithersburg
md
normal
human
sera
sigma
st
loui
mo
concanavalin
sigmaaldrich
ad
cell
incub
day
edu
clickit
alexa
fluor
invitrogen
ad
h
cell
acquir
flow
cytometri
use
facscanto
ii
cytomet
becton
dickinson
lymphoprolifer
analyz
use
facsdiva
softwar
becton
dickinson
determin
differ
fluoresc
intens
mean
mifid
control
cona
well
pbmc
place
plate
x
cell
per
well
rmpi
medium
gibco
gaithersburg
md
normal
human
sera
sigma
st
loui
mo
cytostim
myltenyi
biotec
medium
neg
control
ad
incub
h
supernat
well
collect
cytokin
determin
use
cytometr
bead
array
human
kit
becton
dickinson
follow
manufactur
instruct
includ
tnfalpha
ifngamma
obtain
flow
cytometri
facscanto
ii
analyz
fcap
array
softwar
becton
dickinson
sampl
size
calcul
base
depend
variabl
time
hour
improv
use
g
power
calcul
differ
two
independ
mean
varianc
differ
obtain
previou
public
effect
size
power
alpha
obtain
sampl
size
per
group
total
frequenc
proport
clinic
demograph
variabl
determin
descript
statist
student
pair
ttest
use
contrast
quantit
variabl
chi
squar
use
contrast
qualit
variabl
malnutrit
calcul
z
score
categor
presenc
absenc
analysi
placebo
group
younger
smaller
order
detect
bia
covari
analysi
ancova
done
adjust
age
weight
height
bodi
mass
index
bmi
vaccin
statu
nutrit
statu
depend
variabl
clinic
improv
normal
respiratori
rate
normal
oxygen
satur
p
consid
statist
signific
mean
se
age
zinc
group
month
compar
placebo
group
p
children
placebo
group
lower
weight
height
compar
zinc
group
vs
p
vs
p
respect
male
placebo
group
compar
zinc
group
vs
p
respect
baselin
clinic
symptom
compar
accord
pneumonia
classif
vs
sever
pneumonia
vs
p
oxygen
satur
vs
p
respiratori
rate
mean
se
vs
p
zinc
placebo
group
respect
predomin
radiograph
pattern
interstiti
vs
follow
alveolar
vs
mix
vs
p
zinc
placebo
group
also
compar
percentag
children
rale
fever
cough
respiratori
distress
rhinorrhea
vomit
nasal
flare
costal
retract
group
differ
percentag
symptomat
antibiot
antivir
treatment
group
observ
penicillin
use
empir
treatment
cap
children
hospit
pediatrico
de
coyoacan
ampicillin
hospit
gener
de
accord
local
hospit
guidelin
base
sensit
pattern
tabl
zinc
level
normal
rang
mcgml
baselin
vs
p
treatment
vs
p
differ
found
zinc
placebo
respect
group
increas
zinc
level
supplement
placebo
group
signific
although
zinc
group
show
statist
signific
increas
supplement
p
reach
normal
serum
level
report
tabl
side
effect
report
zinc
placebo
supplement
group
compar
follow
risk
incom
vs
p
malnutrit
vs
p
domest
smoke
vs
p
absenc
breastfeed
vs
p
overcrowd
vs
p
zinc
placebo
group
respect
proport
children
incomplet
vaccin
schedul
higher
placebo
group
vs
p
children
attend
daycar
center
zinc
group
vs
p
tabl
percentag
viral
bacteri
detect
compar
among
vs
one
viru
vs
viral
coinfect
vs
viral
bacteri
coinfect
vs
bacteria
p
zinc
placebo
group
respect
tabl
distribut
viru
bacteria
group
shown
figur
rsv
b
rhinoviru
metapneumoviru
frequent
detect
virus
group
singl
agent
combin
h
influenza
pneumonia
frequent
detect
bacteria
group
singl
agent
combin
incid
pathogen
detect
similar
group
three
pathogen
major
patient
zinc
placebo
group
respect
figur
analysi
viru
supplementari
tabl
bacteria
show
differ
frequenc
among
group
clinic
improv
mean
hour
combin
clinic
variabl
vs
p
normal
respiratori
rate
vs
p
normal
oxygen
satur
vs
p
measur
hour
faster
zinc
group
compar
placebo
group
statist
signific
analysi
covari
adjust
effect
zinc
age
placebo
group
younger
p
found
time
clinic
improv
respiratori
rate
oxygen
satur
mean
younger
age
placebo
group
bia
effect
better
respons
zinc
group
also
weight
height
bmi
gender
vaccin
statu
nutrit
statu
effect
covari
analysi
depend
variabl
statist
signific
differ
normal
respiratori
distress
vs
p
normal
temperatur
vs
p
hour
day
hospit
vs
p
zinc
placebo
group
respect
although
tendenc
observ
tabl
death
report
particip
studi
side
effect
report
children
receiv
zinc
placebo
lymphoprolifer
concanavalin
pbmc
children
pneumonia
measur
edu
clickit
incorpor
compar
zinc
mean
se
differ
intens
placebo
group
p
treatment
vs
p
respect
cytokin
respons
show
increas
pattern
x
sem
x
sem
supplement
zinc
group
x
sem
increas
placebo
group
although
zinc
group
remain
high
cytokin
increas
group
x
sem
zinc
placebo
decreas
x
sem
zinc
placebo
remain
high
group
figur
zinc
defici
alter
innat
adapt
immun
zinc
supplement
improv
immun
amelior
chronic
dysfunct
inflammatori
respons
shown
shorten
durat
decreas
sever
children
diarrhea
sinc
unicef
recommend
zinc
supplement
along
oral
rehydr
case
pneumonia
sever
trial
metaanalys
zinc
supplement
found
benefit
other
limit
improv
found
lack
benefit
compar
placebo
howev
outcom
methodolog
differ
clinic
trial
immunolog
etiolog
assess
conduct
random
tripleblind
control
clinic
trial
use
recommend
dose
zinc
children
diarrhea
children
pneumonia
measur
clinic
symptom
previous
report
mani
rct
translat
approach
measur
cytokin
lymphoprolif
capac
zinc
supplement
serum
zinc
level
detect
etiolog
agent
multiplex
pcr
tri
find
correl
pathogen
clinic
develop
immun
respons
found
zinc
improv
oxygen
satur
tachypnea
clinic
statu
fewer
hour
placebo
group
independ
age
weight
height
bmi
nutrit
vaccin
statu
accord
covari
analysi
correl
increas
cytokin
zinc
group
discharg
patient
zinc
supplement
although
differ
hospit
stay
respiratori
symptom
improv
faster
hospit
attend
verylowincom
popul
discharg
patient
depend
mani
factor
exampl
patient
improv
stay
hospit
finish
antibiot
treatment
due
lack
resourc
buy
antibiot
administr
reason
like
payment
hospit
lack
money
parent
consid
hospit
stay
length
good
clinic
marker
improv
countri
look
clinic
marker
respiratori
distress
oxygen
satur
tachypnea
denot
clinic
improv
children
virus
respons
case
pneumonia
children
younger
year
old
virus
intracellular
pathogen
strong
cellular
immun
respons
need
case
group
infer
increas
proinflammatori
cytokin
cytokin
took
place
time
entranc
pathogen
organ
develop
pneumonia
demonstr
lymphoprolifer
detect
moment
pneumonia
slight
decreas
resolut
blood
draw
taken
persist
level
time
detect
observ
group
could
either
import
system
pulmonari
inflamm
zinc
defici
associ
product
proinflammatori
cytokin
group
serum
zinc
level
normal
despit
zinc
supplement
moment
admiss
pneumonia
discharg
noteworthi
show
statist
signific
increas
placebo
group
zinc
group
high
level
admiss
pneumonia
persist
discharg
compar
placebo
group
last
measur
figur
increas
zinc
supplement
compar
placebo
suggest
promot
cellmedi
immun
humor
immun
also
shown
decreas
cellmedi
immun
could
result
faster
improv
clinic
symptom
compar
placebo
group
downregulatori
cytokin
increas
resolut
group
expect
inflammatori
respons
take
place
cytokin
necessari
return
basal
state
group
inflamm
take
place
due
pathogen
immun
respons
demonstr
high
level
proinflammatori
cytokin
mononuclear
prolifer
basal
blood
sampl
explanatori
model
shown
supplementari
figur
base
cytokin
lymphoprolifer
respons
accord
time
blood
draw
children
placebo
group
lower
weight
height
could
confound
variabl
although
month
younger
would
explain
differ
noteworthi
malnutrit
show
differ
group
differ
age
adjust
age
weight
height
bmi
effect
zinc
respiratori
paramet
covari
analysi
show
effect
mean
younger
age
bia
better
respons
zinc
group
anoth
risk
factor
higher
placebo
group
incomplet
vaccin
schedul
vs
p
placebo
vs
zinc
respect
although
result
multiplex
rtpcr
show
high
proport
patient
viral
infect
coinfect
prevent
vaccin
includ
mexican
vaccin
program
viru
detect
pcr
includ
nation
vaccin
program
influenza
case
influenza
group
compar
also
pneumonia
nation
vaccin
program
group
show
equal
frequenc
one
limit
studi
mother
provid
vaccin
record
could
analyz
differ
specif
vaccin
among
group
could
corrobor
vaccin
receiv
child
zinc
level
increas
treatment
group
compar
placebo
normal
level
admiss
hospit
pneumonia
also
discharg
despit
supplement
possibl
zinc
deplet
consumpt
pbmc
neutrophil
inflammatori
respons
use
bacteria
drive
key
cellular
process
infect
also
possibl
children
attend
hospit
verylowincom
popul
zinc
defici
due
malnutrit
group
could
basal
state
children
control
healthi
subject
would
suitabl
answer
question
also
possibl
higher
dose
longer
durat
treatment
zinc
would
achiev
better
serum
zinc
level
base
intervent
describ
studi
dose
zinc
show
benefit
noteworthi
placebo
group
also
present
tendenc
increas
zinc
level
although
signific
could
relat
balanc
food
given
hospit
verylowincom
children
although
found
mani
combin
virus
bacteria
capac
detect
multipl
bacteria
nasal
wash
hard
interpret
genet
materi
detect
multiplex
pcr
absenc
bronchial
cultur
blood
cultur
detect
could
bacteri
colon
describ
nasopharynx
healthi
subject
case
virus
unknown
colon
detect
inflamm
diseas
exist
correl
clinic
immunolog
etiolog
agent
could
made
due
larg
number
combin
virus
andor
bacteria
proport
viral
bacteri
combin
detect
compar
group
controversi
zinc
supplement
children
pneumonia
base
clinic
trial
zinc
administ
clinic
outcom
measur
attempt
add
clinic
evid
context
random
control
trial
extens
publish
rather
look
immunolog
evid
effect
zinc
children
pneumonia
translat
studi
report
immunolog
evid
patholog
human
littl
patient
studi
patient
group
add
immun
evid
zinc
supplement
children
pneumonia
first
studi
provid
immunolog
evid
respons
context
random
control
clinic
trial
translat
medicin
appli
immunolog
pattern
detect
correl
clinic
outcom
zinc
supplement
show
benefit
shorten
durat
oxygen
desatur
tachypnea
clinic
symptom
children
pneumonia
show
respons
increas
cytokin
zinc
supplement
along
standard
protocol
treatment
could
explor
recommend
children
pneumonia
constitut
one
frequent
caus
morbid
mortal
children
younger
year
old
dataset
gener
studi
avail
request
correspond
author
studi
approv
institut
review
board
faculti
medicin
universidad
nacion
de
hospit
gener
de
hospit
de
written
consent
obtain
parent
guardian
procedur
follow
accord
ethic
standard
helsinki
declar
previou
affili
rosa
wongchew
miguel
leonardo
jorg
lui
santiagocordova
alejandra
pamela
unidad
de
en
medicina
experiment
facultad
de
medicina
unam
dr
balmi
colonia
doctor
df
work
present
part
abstract
annual
meet
mexicana
de
san
lui
may
monterrey
may
ix
nation
virolog
meet
puent
de
ixtla
morelo
novemb
rwc
report
person
fee
sanofi
pasteur
speaker
gsk
abbvi
advisori
board
outsid
submit
work
remain
author
declar
research
conduct
absenc
commerci
financi
relationship
could
constru
potenti
conflict
interest
